 | |||||
| program | |||||
| NEWS | |||||
| Cellares Announces Bristol Myers Squibb has Joined Technology Adoption Partnership ... Cellares' TAP program is a fast and low-risk opportunity for cell therapy developers to adopt the company's automated manufacturing technology for ...
| |||||
| See more results | Edit this alert | |||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment